The inquiry, obtained first by CNBC, highlights mounting political and regulatory scrutiny surrounding the intersection of commercial prediction markets and public health oversight. Platforms such as Kalshi and Polymarket have expanded their financial offerings into the biopharmaceutical sector, allowing retail and institutional participants to wager on the outcomes of complex medical research and federal drug […]